Interventional Radiology Section, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO; and.
Division of Vascular and Interventional Radiology, New York University Langone School of Medicine, New York, NY.
Blood. 2018 Feb 15;131(7):733-740. doi: 10.1182/blood-2016-11-693663. Epub 2018 Jan 2.
Patients who present with severe manifestations of acute venous thromboembolism (VTE) are at higher risk for premature death and long-term disability. In recent years, catheter-based interventional procedures have shown strong potential to improve clinical outcomes in selected VTE patients. However, physicians continue to be routinely faced with challenging decisions that pertain to the utilization of these risky and costly treatment strategies, and there is a relative paucity of published clinical trials with sufficient rigor and directness to inform clinical practice. In this article, using 3 distinct clinical scenario presentations, we draw from the available published literature describing the natural history, pathophysiology, treatments, and outcomes of VTE to illustrate the key factors that should influence clinical decision making for patients with severe manifestations of deep vein thrombosis and pulmonary embolism. The results of a recently completed pivotal multicenter randomized trial are also discussed.
患有严重急性静脉血栓栓塞症(VTE)的患者有过早死亡和长期残疾的更高风险。近年来,基于导管的介入治疗程序在选定的 VTE 患者中显示出改善临床结果的强大潜力。然而,医生在选择这些有风险和昂贵的治疗策略时,仍然需要经常做出具有挑战性的决策,并且发表的临床试验相对较少,缺乏足够的严谨性和直接性来为临床实践提供信息。在本文中,我们通过 3 个不同的临床情景介绍,利用现有的描述 VTE 的自然史、病理生理学、治疗和结果的已发表文献,说明影响深静脉血栓形成和肺栓塞严重表现患者临床决策的关键因素。还讨论了最近完成的一项关键性多中心随机试验的结果。